COPD in the 21st Century -

COPD in the 21st Century

Buch | Softcover
2024
European Respiratory Society (Verlag)
978-1-84984-175-7 (ISBN)
89,95 inkl. MwSt
  • Titel nicht im Sortiment
  • Artikel merken
COPD remains a major cause of ill health, disability, healthcare costs and premature mortality. Scientists and clinicians across many countries have made great efforts to understand this important disease, and these have yielded positive results. This Monograph provides an up-to-date overview of what is happening in this exciting field, both at a basic and a clinical level. Beginning, crucially, with the patient’s perspective, the chapters that follow consider the best way to define COPD, changes in the disease’s incidence and prevalence, and offer new insights into the role of the microbiome in COPD, advances in imaging and treatment options, both pharmacological and non-pharmacological. Taken together, these chapters are an important contribution to the Monograph series and the COPD field in general.

Jadwiga A. Wedzicha is Professor of Respiratory Medicine, Head of the Respiratory Division at the National Heart and Lung Institute (Imperial College London, London, UK), Consul at Imperial College and Honorary Consultant at the Royal Brompton and Harefield Hospitals (London, UK). James P. Allinson is Consultant Respiratory Physician at the Royal Brompton Hospital (London, UK) and an honorary Senior Clinical Lecturer at the National Heart and Lung Institute (Imperial College London, London, UK). Peter M.A. Calverley is Emeritus Professor of Respiratory Medicine at the University of Liverpool (Liverpool, UK) and continues to work in the Institute of Life Courses and Medical Science (University of Liverpool).

The patients’ perspective on living with COPD and their priorities for future research and care; COPD as the new millennium began; Defining COPD in the 21st century; A new understanding of the natural history of COPD; The new epidemiology of COPD; Cardiac comorbidity and COPD: chance or consequence?; Mechanisms and medicators of disease; The microbiome and COPD; Chronic bronchitis revisited; Eosinophils and COPD; Advances in the characterisation of COPD using quantitative imaging; New physiological measurements in COPD; Guidelines and strategies of management; Current pharmacotherapy of COPD; The future drug treatment of COPD; The future of pulmonary rehabilitation in COPD; New insights into the pathophysiology and epidemiology of COPD exacerbations; Managing exacerbations of COPD: how much progress have we made?; Noninvasive ventilation in COPD; Lung volume reduction for emphysema; COPD at a tipping point

Erscheinungsdatum
Reihe/Serie ERS Monograph ; 103
Verlagsort Sheffield
Sprache englisch
Themenwelt Medizinische Fachgebiete Innere Medizin Pneumologie
ISBN-10 1-84984-175-6 / 1849841756
ISBN-13 978-1-84984-175-7 / 9781849841757
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Atemphysiologie und Beatmungstechnik

von Wolfgang Oczenski

Buch (2023)
Thieme (Verlag)
110,00

von Ulrich Costabel; Robert Bals; Christian Taube; Claus Kroegel

Buch (2024)
Thieme (Verlag)
299,99